KYMR kymeratx.com Net earnings per share growth forecast for next year

Corporate company logo of Kymera Corp (KYMR)

Kymera Therapeutics (KYMR) is developing innovative methods for eliminating pathogenic proteins, opening new horizons in tumor treatment. The earnings per share growth forecast trend confirms this potential, where the -30.70 indicator expresses the state of the metric. However, the absence of commercial sales leaves the company dependent on grants. Meanwhile, geopolitical instability creates risks for raw material logistics and the execution of global trials.

KYMR: Kymera Therapeutics, Inc. Net earnings per one share growth forecast for next year 07/04/2022 - 11/18/2026

Financial and market metric breakdowns for Kymera (KYMR)

- share price and consensus valuation forecast:
Fundamental company analysis:Kymera, KYMR
Brand item of kymeratx.com

This indicator measures the expected earnings per share (EPS) dynamics by combining current market valuations and real-time fundamental model adjustments. By analyzing the current trajectory of next year's EPS forecasts, investors assess the capitalization potential of Kymera Therapeutics (KYMR) through the lens of the commercial success of its innovative TPD drugs for oncology and immunology therapies.

Competing companies

GMAB (Genmab Corp) - Earnings growth forecast for next year|Earnings growth forecast for next year exelixis.com|Net earnings per share growth forecast for next year Nuvalent (NUVL)|IDYA (IDEAYA Biosciences, Inc.) - Expected earnings per share trend next year|Earnings growth forecast for next year ELVN (Enliven Therapeutics Inc)|Net earnings per one share growth forecast for next year ORIC Pharma|Relay Therapeutics Inc - Earnings growth forecast for next year|Expected net earnings per share growth next year Nurix Therapeutics, Inc.|TYRA (Tyra Biosciences, Inc.) - Expected earnings per share growth for next year|VSTM: Projected earnings per share increase next year|GLUE (monterosatx.com) - Earnings growth forecast for next year|Expected net earnings per share growth next year Cullinan Therapeutics Inc CGEM|Earnings growth forecast for next year IMRX|C4 Therapeutics - Projected earnings per share growth rate for next year|Black Diamond Therapeutics - Expected earnings per share growth for next year|Expected earnings per share trend next year RPTX|PMVP: Expected earnings per share growth for next year|karyopharm.com - Projected earnings per share increase next year|PPCB: Earnings growth forecast for next year|Bio Green Med Solution Inc - Expected earnings per share trend next year|AADI (Aadi Bioscience Inc) - Earnings growth forecast for next year|Expected net earnings per share growth next year aileronrx.com ALRN|Net earnings per share growth forecast for next year Blueprint Medicines Corp. (BPMC)|GLYC (GlycoMimetics) - Expected earnings per share trend next year|Earnings growth forecast for next year SWTX (SpringWorks Therapeutics, Inc)